X-72301950-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001144887.2(CITED1):āc.355G>Cā(p.Gly119Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00213 in 1,210,867 control chromosomes in the GnomAD database, including 2 homozygotes. There are 880 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0013 ( 0 hom., 49 hem., cov: 24)
Exomes š: 0.0022 ( 2 hom. 831 hem. )
Consequence
CITED1
NM_001144887.2 missense
NM_001144887.2 missense
Scores
1
3
13
Clinical Significance
Conservation
PhyloP100: 0.260
Genes affected
CITED1 (HGNC:1986): (Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1) This gene encodes a member of the CREB-binding protein/p300-interacting transactivator with Asp/Glu-rich C-terminal domain (CITED) family of proteins. The encoded protein, also known as melanocyte-specific gene 1, may function as a transcriptional coactivator and may play a role in pigmentation of melanocytes. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jan 2009]
PIN4 (HGNC:8992): (peptidylprolyl cis/trans isomerase, NIMA-interacting 4) This gene encodes a member of the parvulin subfamily of the peptidyl-prolyl cis/trans isomerase protein family. The encoded protein catalyzes the isomerization of peptidylprolyl bonds, and may play a role in the cell cycle, chromatin remodeling, and/or ribosome biogenesis. The encoded protein may play an additional role in the mitochondria. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0067691505).
BS2
High Hemizygotes in GnomAd4 at 49 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CITED1 | NM_001144887.2 | c.355G>C | p.Gly119Arg | missense_variant | 3/3 | ENST00000651998.1 | NP_001138359.1 | |
CITED1 | NM_001144885.2 | c.433G>C | p.Gly145Arg | missense_variant | 4/4 | NP_001138357.1 | ||
CITED1 | NM_001144886.2 | c.355G>C | p.Gly119Arg | missense_variant | 3/3 | NP_001138358.1 | ||
CITED1 | NM_004143.4 | c.355G>C | p.Gly119Arg | missense_variant | 3/3 | NP_004134.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CITED1 | ENST00000651998.1 | c.355G>C | p.Gly119Arg | missense_variant | 3/3 | NM_001144887.2 | ENSP00000499148.1 | |||
ENSG00000285547 | ENST00000648922.1 | c.1531G>C | p.Gly511Arg | missense_variant | 12/12 | ENSP00000497072.1 |
Frequencies
GnomAD3 genomes AF: 0.00135 AC: 152AN: 112839Hom.: 0 Cov.: 24 AF XY: 0.00140 AC XY: 49AN XY: 34967
GnomAD3 genomes
AF:
AC:
152
AN:
112839
Hom.:
Cov.:
24
AF XY:
AC XY:
49
AN XY:
34967
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00166 AC: 302AN: 181951Hom.: 0 AF XY: 0.00198 AC XY: 132AN XY: 66613
GnomAD3 exomes
AF:
AC:
302
AN:
181951
Hom.:
AF XY:
AC XY:
132
AN XY:
66613
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00221 AC: 2422AN: 1097975Hom.: 2 Cov.: 30 AF XY: 0.00229 AC XY: 831AN XY: 363349
GnomAD4 exome
AF:
AC:
2422
AN:
1097975
Hom.:
Cov.:
30
AF XY:
AC XY:
831
AN XY:
363349
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00135 AC: 152AN: 112892Hom.: 0 Cov.: 24 AF XY: 0.00140 AC XY: 49AN XY: 35030
GnomAD4 genome
AF:
AC:
152
AN:
112892
Hom.:
Cov.:
24
AF XY:
AC XY:
49
AN XY:
35030
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
3
ALSPAC
AF:
AC:
5
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
10
ExAC
AF:
AC:
176
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.433G>C (p.G145R) alteration is located in exon 4 (coding exon 3) of the CITED1 gene. This alteration results from a G to C substitution at nucleotide position 433, causing the glycine (G) at amino acid position 145 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;T;T;T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;T;.;.;T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;.;M;M;M;.;.
MutationTaster
Benign
N;N;N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;N;N;D;.
REVEL
Benign
Sift
Benign
T;T;D;D;D;D;.
Sift4G
Benign
T;T;T;T;T;.;.
Polyphen
P;P;B;B;B;.;.
Vest4
MutPred
0.43
.;.;Loss of catalytic residue at P115 (P = 0.0722);Loss of catalytic residue at P115 (P = 0.0722);Loss of catalytic residue at P115 (P = 0.0722);Loss of catalytic residue at P115 (P = 0.0722);.;
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at